Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

420 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Alignment of Qx100/Qx200 Droplet Digital (Bio-Rad) and QuantStudio 3D (Thermofisher) Digital PCR for Quantification of BCR-ABL1 in Ph+ Chronic Myeloid Leukemia.
Fava C, Bernardi S, Gottardi EM, Lorenzatti R, Galeotti L, Ceccherini F, Cordoni F, Daraio F, Giugliano E, Jovanovski A, Petiti J, Varotto M, Barberio D, Rege-Cambrin G, Berchialla P, Sciannameo V, Malagola M, Saglio G, Russo D. Fava C, et al. Diseases. 2021 May 5;9(2):35. doi: 10.3390/diseases9020035. Diseases. 2021. PMID: 34062996 Free PMC article.
Standardization of BCR-ABL1 p210 Monitoring: From Nested to Digital PCR.
Jovanovski A, Petiti J, Giugliano E, Gottardi EM, Saglio G, Cilloni D, Fava C. Jovanovski A, et al. Among authors: fava c. Cancers (Basel). 2020 Nov 6;12(11):3287. doi: 10.3390/cancers12113287. Cancers (Basel). 2020. PMID: 33172063 Free PMC article. Review.
BCR-ABL1 mutation ≠ ponatinib resistance.
Saglio G, Fava C. Saglio G, et al. Among authors: fava c. Blood. 2016 Feb 11;127(6):666-7. doi: 10.1182/blood-2015-12-685149. Blood. 2016. PMID: 26869304 Free article. No abstract available.
Early BCR-ABL1 Reduction Is Predictive of Better Event-free Survival in Patients With Newly Diagnosed Chronic Myeloid Leukemia Treated With Any Tyrosine Kinase Inhibitor.
Fava C, Rege-Cambrin G, Dogliotti I, Gottardi E, Berchialla P, Di Gioacchino B, Crasto F, Lorenzatti R, Volpengo A, Daraio F, Fantino C, Saglio G. Fava C, et al. Clin Lymphoma Myeloma Leuk. 2016 Aug;16 Suppl:S96-S100. doi: 10.1016/j.clml.2016.03.008. Epub 2016 Apr 1. Clin Lymphoma Myeloma Leuk. 2016. PMID: 27131622 Review.
Novel Multiplex Droplet Digital PCR Assays to Monitor Minimal Residual Disease in Chronic Myeloid Leukemia Patients Showing Atypical BCR-ABL1 Transcripts.
Petiti J, Lo Iacono M, Dragani M, Pironi L, Fantino C, Rapanotti MC, Quarantelli F, Izzo B, Divona M, Rege-Cambrin G, Saglio G, Gottardi EM, Cilloni D, Fava C. Petiti J, et al. Among authors: fava c. J Clin Med. 2020 May 13;9(5):1457. doi: 10.3390/jcm9051457. J Clin Med. 2020. PMID: 32414125 Free PMC article.
Treatment-Free Remission in Chronic Myeloid Leukemia Harboring Atypical BCR-ABL1 Transcripts.
Dragani M, Petiti J, Rege-Cambrin G, Gottardi E, Daraio F, Caocci G, Aguzzi C, Crisà E, Andreani G, Caciolli F, Fava C. Dragani M, et al. Among authors: fava c. Mediterr J Hematol Infect Dis. 2020 Sep 1;12(1):e2020066. doi: 10.4084/MJHID.2020.066. eCollection 2020. Mediterr J Hematol Infect Dis. 2020. PMID: 32952977 Free PMC article. No abstract available.
420 results